Results 51 to 60 of about 41,567 (239)
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Background Alzheimer’s disease (AD) is a neurologically degenerative disorder that affects more than 20 million people worldwide. The selective butyrylcholinesterase (BChE) inhibitors and bivalent cholinesterase (ChE) inhibitors represent new treatments ...
Wang Yue-Hu +4 more
doaj +1 more source
Background Anticholinergic medications are drugs that block cholinergic transmission, either as their primary therapeutic action or as a secondary effect.
Annabelle Hook +29 more
doaj +1 more source
Potentiation Between Cholinesterase Inhibitors.
SummaryOrganic phosphate insecticides EPN, malathion, chlorothion and phostex, in all possible paired combinations administered simultaneously to mice showed potentiation in their oral toxicities. Some potentiation was observed even when EPN was given 24 hours before malathion.
P, ROSENBERG, J M, COON
openaire +2 more sources
ABSTRACT Alzheimer's disease (AD) is one of the most common neurological disorders affecting older adults, with approximately 7.2 million cases only in the United States. This number is projected to increase to 13.8 million in the United States by 2060, leading to increased expenditures for healthcare, long‐term care and hospice services. Consequently,
Valentina Zecca +3 more
wiley +1 more source
Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex
Antipsychotics are often the first-line treatment for behavioral and psychological symptoms of dementia. However, the potential anticholinergic effects of antipsychotics could counteract the therapeutic effects of cholinesterase inhibitors used to treat ...
Keisuke Obara +7 more
doaj +1 more source
Abstract Background Malnutrition is common among patients with decompensated liver cirrhosis and linked to poor prognosis. Guidelines recommend intensified nutrition support e.g. parenteral nutrition, but evidence regarding safety and effectiveness is scarce. We aimed to investigate the impact of nutrition support, specifically parenteral nutrition, on
Katharina L. Hupa‐Breier +10 more
wiley +1 more source
CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
Dementia is the loss of intellectual abilities which include decreased ability to think, remember,understand, calculate, concentrate, and find the right words. The causes of dementia areAlzheimer’s, vascular dementia, alcohol.
Prameidya Primaniar S
doaj
Difficulties in Diagnosing a Case of Myasthenia Crisis
A 26 year old, female presented to EMD in severe respiratory distress. Patient had history of breathlessness since past one month with h/o intrauterine death 1month back .On further investigation it was found that anti acetylcholine receptor ...
Atishaya G V +3 more
doaj +1 more source
Antihypertensive treatment in people with dementia [PDF]
Introduction The range and magnitude of potential benefits and harms of antihypertensive treatment in people with dementia has not been previously established.
Andersson +58 more
core +2 more sources

